CDSCO Panel Defers Biosphere's Colloidal Nano Silver Gel Trial, Seeks Full Data Parthika Patel29 Aug 2025 10:44 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has deferred further action on...
State Drug Alert: Ciprofloxacin, Lorazepam, Albendazole Among 97 NSQ Samples Flagged in July Susmita Roy29 Aug 2025 5:12 PM ISTNew Delhi: Reflecting ongoing concerns around drug quality in India's pharmaceutical supply chain, the Central Drugs Standard Control Organisation...
46 Drug Batches Fail CDSCO Quality Test In July, Details Susmita Roy28 Aug 2025 9:03 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has declared 46 batches of medicines as "Not of Standard Quality" (NSQ) after drug...
CDSCO Flags 8 Batches of Spurious Medicines, Including Popular Brands Augmentin, PAN 40 Susmita Roy28 Aug 2025 8:53 PM ISTNew Delhi: In a disclosure that raises serious concerns over drug safety, the Central Drugs Standard Control Organisation (CDSCO) has flagged eight...
Sun Pharma Wins CDSCO Panel Approval for Phase III Vitiligo Trial of Ruxolitinib Cream Susmita Roy26 Aug 2025 12:00 PM ISTNew Delhi: Based on the justification presented by the pharmaceutical major Sun Pharmaceutical Industries, the Subject Expert Committee (SEC)...
CDSCO Panel Asks Unique Biotech to Submit Approval Status of Bacillus coagulans Unique IS-2 2 Billion CFU Susmita Roy25 Aug 2025 4:00 PM ISTNew Delhi: In line with the proposal regarding the combination of an osmotic laxative and a probiotic, which is Lactulose 10 gm plus Bacillus...
Mandatory Excipients Disclosure on Drug Labels from March 2026: Health Ministry Parthika Patel24 Aug 2025 5:33 PM ISTNew Delhi: All drug labels will now be required to clearly disclose the qualitative details of excipients along with the date of expiry, as the Union...
CDSCO Panel Rejects Phase III Trial of QL2107 Injection Proposed by Syneos Health Parthika Patel24 Aug 2025 4:20 PM ISTNew Delhi: In a setback to Syneos Health India Private Limited, the Indian arm of the global contract research organization Syneos Health, the Subject...
Ravenbhel's Bilastine, Montelukast FDC Under Review, CDSCO Panel Seeks Pediatric Expert Opinion Dr. Divya Colin22 Aug 2025 6:38 PM ISTNew Delhi: In response to a proposal submitted by Ravenbhel Healthcare of the fixed dose combination (FDC) pulmonary drug Bilastine 10 mg plus...
CDSCO Digitisation Cuts Post-Approval Change Timelines in CGTs from 218 to 98 Days: DCGI Parthika Patel22 Aug 2025 6:12 PM ISTNew Delhi: The Drug Controller General of India (DCGI), Central Drugs Standard Control Organisation (CDSCO), Dr Rajeev Raghuvanshi, has recently...
CDSCO Panel Approves Emcure's Phase III Clinical Trial of Semaglutide, Mandates Govt Trial Sites Susmita Roy21 Aug 2025 6:53 PM ISTNew Delhi: Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma Susmita Roy20 Aug 2025 4:20 PM ISTNew Delhi: Following a thorough discussion on the proposed Phase III clinical trial protocol for roflumilast cream, the Subject Expert Committee (SEC)...
